Financial Health Report: Novavax, Inc (NVAX)’s Ratios Tell a Tale

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

Novavax, Inc (NASDAQ: NVAX) closed the day trading at $8.43 down -2.99% from the previous closing price of $8.69. In other words, the price has decreased by -$2.99 from its previous closing price. On the day, 2.29 million shares were traded. NVAX stock price reached its highest trading level at $8.6 during the session, while it also had its lowest trading level at $8.31.

Ratios:

For a better understanding of NVAX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.93 and its Current Ratio is at 0.93.

BofA Securities Upgraded its Underperform to Neutral on May 10, 2024, whereas the target price for the stock was revised from $4 to $12.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 ’24 when King Rachel K. sold 4,150 shares for $9.02 per share. The transaction valued at 37,435 led to the insider holds 14,770 shares of the business.

YOUNG JAMES F sold 5,400 shares of NVAX for $43,200 on Dec 31 ’24. The Director now owns 51,760 shares after completing the transaction at $8.00 per share. On Dec 24 ’24, another insider, YOUNG JAMES F, who serves as the Director of the company, sold 4,600 shares for $8.48 each. As a result, the insider received 39,008 and left with 57,160 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 1350359552 and an Enterprise Value of 703053504. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53. Its current Enterprise Value per Revenue stands at 0.794 whereas that against EBITDA is -2.89.

Stock Price History:

The Beta on a monthly basis for NVAX is 2.13, which has changed by 1.211196 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $3.53. The 50-Day Moving Average of the stock is -4.05%, while the 200-Day Moving Average is calculated to be -23.86%.

Shares Statistics:

Over the past 3-months, NVAX traded about 4.67M shares per day on average, while over the past 10 days, NVAX traded about 4052510 shares per day. A total of 160.15M shares are outstanding, with a floating share count of 152.94M. Insiders hold about 4.52% of the company’s shares, while institutions hold 59.81% stake in the company. Shares short for NVAX as of 1736899200 were 38069559 with a Short Ratio of 8.15, compared to 1734048000 on 39157237. Therefore, it implies a Short% of Shares Outstanding of 38069559 and a Short% of Float of 29.639998000000002.

Most Popular